Enhancement of Acute Phase and Inhibition of Chronic Phase of Experimental Autoimmune Neuritis in Lewis Rats by Intranasal Administration of Recombinant Mouse Interleukin 17: Potential Immunoregulatory Role
- 31 May 2000
- journal article
- Published by Elsevier BV in Experimental Neurology
- Vol. 163 (1), 165-172
- https://doi.org/10.1006/exnr.2000.7357
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Cytokine Dichotomy in Peripheral Nervous System Influences the Outcome of Experimental Allergic Neuritis: Dynamics of mRNA Expression for IL-1β, IL-6, IL-10, IL-12, TNF-α, TNF-β, and CytolysinClinical Immunology and Immunopathology, 1997
- Interleukin (IL)-6 Directs the Differentiation of IL-4–producing CD4+ T CellsThe Journal of Experimental Medicine, 1997
- T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines.The Journal of Experimental Medicine, 1996
- Suppression of the Immune Response by Nasal ImmunizationClinical Immunology and Immunopathology, 1994
- Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinityInternational Immunology, 1993
- Nerve lesions induced by macrophage activationResearch in Immunology, 1992
- The nasal delivery of peptides and proteinsTrends in Biotechnology, 1991
- Lymphokine Control of In Vivo Immunoglobulin Isotype SelectionAnnual Review of Immunology, 1990
- Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor responseCell, 1990
- A T cell epitope for experimental allergic neuritisJournal of Neuroimmunology, 1988